Found: 33
Select item for more details and to access through your institution.
Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 6, p. 1267, doi. 10.1007/s10637-015-0297-4
- By:
- Publication type:
- Article
Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases.
- Published in:
- 2011
- By:
- Publication type:
- Report
A potentially neuroprotective role for erythropoietin with paclitaxel treatment in ovarian cancer patients: a prospective phase II GINECO trial.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 7, p. 1947, doi. 10.1007/s00520-013-1748-0
- By:
- Publication type:
- Article
Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e245552, doi. 10.1001/jamanetworkopen.2024.5552
- By:
- Publication type:
- Article
Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 17, p. 1338, doi. 10.1093/jnci/djr282
- By:
- Publication type:
- Article
Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).
- Published in:
- 2004
- By:
- Publication type:
- commentary
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensitive recurrent ovarian cancer.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 3, p. 425, doi. 10.1038/s41416-023-02528-z
- By:
- Publication type:
- Article
Human pharmacokinetics of N-L-leucyl-doxorubicin, a new anthracycline derivative, and its correlation with clinical toxicities.
- Published in:
- Clinical Pharmacology & Therapeutics, 1992, v. 51, n. 3, p. 249, doi. 10.1038/clpt.1992.19
- By:
- Publication type:
- Article
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Left Ventricular Ejection Fraction in Patients With Ovarian Cancer Treated With Avelumab, Pegylated Liposomal Doxorubicin, or Both.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e977, doi. 10.1093/oncolo/oyad213
- By:
- Publication type:
- Article
Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours.
- Published in:
- PLoS ONE, 2008, v. 3, n. 12, p. 1, doi. 10.1371/journal.pone.0003894
- By:
- Publication type:
- Article
Molecular and clinical predictors of improvement in progression‐free survival with maintenance PARP inhibitor therapy in women with platinum‐sensitive, recurrent ovarian cancer: A meta‐analysis.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 14, p. 2432, doi. 10.1002/cncr.33517
- By:
- Publication type:
- Article
Once-Weekly Treatment of Anemia in Patients with Cancer: A Comparative Review of Epoetins.
- Published in:
- Oncology, 2005, v. 68, n. 2/3, p. 122, doi. 10.1159/000086957
- By:
- Publication type:
- Article
The Burden of Anaemia in Patients with Cancer.
- Published in:
- Oncology, 2004, v. 67, p. 1, doi. 10.1159/000080702
- By:
- Publication type:
- Article
Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919849753
- By:
- Publication type:
- Article
Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919849753
- By:
- Publication type:
- Article
Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 6, p. 1234, doi. 10.1002/cncr.24149
- By:
- Publication type:
- Article
Assessment of Progression-Free Survival as a Surrogate End Point of Overall Survival in First-Line Treatment of Ovarian Cancer: A Systematic Review and Meta-analysis.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 1, p. e1918939, doi. 10.1001/jamanetworkopen.2019.18939
- By:
- Publication type:
- Article
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00832
- By:
- Publication type:
- Article
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.
- Published in:
- Journal of Gynecologic Oncology, 2021, v. 32, n. 5, p. 1, doi. 10.3802/jgo.2021.32.e82
- By:
- Publication type:
- Article
Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference.
- Published in:
- 2017
- By:
- Publication type:
- Proceeding
Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
CXCL12 expression by healthy and malignant ovarian epithelial cells.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 97, doi. 10.1186/1471-2407-11-97
- By:
- Publication type:
- Article
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 6, p. 1998, doi. 10.1007/s00259-020-05092-3
- By:
- Publication type:
- Article
CA-125 Early Dynamics to Predict Overall Survival in Women with Newly Diagnosed Advanced Ovarian Cancer Based on Meta-Analysis Data.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1823, doi. 10.3390/cancers15061823
- By:
- Publication type:
- Article
Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092345
- By:
- Publication type:
- Article
A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 6, p. 489, doi. 10.1007/s00280-004-0762-9
- By:
- Publication type:
- Article
Gene expression markers in peripheral blood and outcome in patients with platinum‐resistant ovarian cancer: A study of the European GANNET53 consortium.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 6, p. 1128, doi. 10.1002/ijc.34978
- By:
- Publication type:
- Article
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study.
- Published in:
- Oncology Letters, 2016, v. 11, n. 3, p. 1859, doi. 10.3892/ol.2016.4146
- By:
- Publication type:
- Article
HER2 Overexpression/Amplification and Trastuzumab Treatment in Advanced Ovarian Cancer: A GINECO Phase II Study.
- Published in:
- Clinical Ovarian Cancer, 2008, v. 1, n. 1, p. 54, doi. 10.3816/COC.2008.n.005
- By:
- Publication type:
- Article
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancerSee related article on pages 692–702, this issue.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 4, p. 645, doi. 10.1002/cncr.22467
- By:
- Publication type:
- Article
Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab.
- Published in:
- 2016
- By:
- Publication type:
- journal article